PAYC vs PMCB · P/E 33, rev $1.10B vs $8.6M cap
Paycom Soft (PAYC) versus PharmaCyte Biotech Inc (PMCB) — a side-by-side from cached financials, not a winner call.
Paycom Soft (PAYC) is a software - application company listed on US.
PharmaCyte Biotech Inc (PMCB) is a biotechnology company listed on NASDAQ.
Latest reported PAYC revenue for 2026-06-30 was $1.10B. Net income was $263.1M. Revenue was up 92.9% from 2026-03-31 to 2026-06-30. PAYC currently screens at market cap $13.06B and trailing P/E 33.1.
Latest reported PMCB revenue for 2026-04-30 was $0. Net income was -$19.4M. PMCB currently screens at market cap $8.6M.
PAYC currently screens at market cap $13.06B and trailing P/E 33.1. PMCB currently screens at market cap $8.6M.
Not investment advice. Open the PAYC and PMCB stock pages for the full models.
Not investment advice.